Irma Bisceglia

Rome, 00152, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer.

Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer.

Journal: Cardio-oncology (London, England)

Published: June 03, 2026

Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

Journal: International journal of molecular sciences

Published: May 04, 2026

Cholesterol metabolism in patients with cancer: pathophysiology, therapeutic options, and future perspectives

Cholesterol metabolism in patients with cancer: pathophysiology, therapeutic options, and future perspectives

Journal: Giornale italiano di cardiologia (2006)

Published: April 29, 2026

SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

Journal: International journal of molecular sciences

Published: March 12, 2026

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Journal: Cancer

Published: January 21, 2026

Sodium-glucose cotransporter 2 inhibitors in breast cancer patients on endocrine therapy: a targeted strategy to mitigate long-term cardiometabolic risk.

Sodium-glucose cotransporter 2 inhibitors in breast cancer patients on endocrine therapy: a targeted strategy to mitigate long-term cardiometabolic risk.

Journal: Journal of translational medicine

Published: January 19, 2026

Management of Implantable Cardiovascular Devices in Patients Undergoing Radiotherapy.

Management of Implantable Cardiovascular Devices in Patients Undergoing Radiotherapy.

Journal: Diagnostics (Basel, Switzerland)

Published: January 06, 2026

Cardiovascular Disease and Cancer: Two Sides of the Same Coin.

Cardiovascular Disease and Cancer: Two Sides of the Same Coin.

Journal: Cardiology

Published: October 30, 2025

Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology

Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology

Journal: Giornale italiano di cardiologia (2006)

Published: October 02, 2025

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Journal: International journal of molecular sciences

Published: August 23, 2025

Management of cardiac implantable electronic devices in cancer patients undergoing radiotherapy. An Italian Association of Hospital Cardiologists (ANMCO) statement

Management of cardiac implantable electronic devices in cancer patients undergoing radiotherapy. An Italian Association of Hospital Cardiologists (ANMCO) statement

Journal: Giornale italiano di cardiologia (2006)

Published: July 28, 2025

Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients.

Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients.

Journal: Journal of cardiovascular pharmacology

Published: July 14, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026